Skip to main content
. Author manuscript; available in PMC: 2021 Aug 20.
Published in final edited form as: Cell Chem Biol. 2020 Aug 13;27(8):904–920. doi: 10.1016/j.chembiol.2020.07.022

Figure 3. Synthetic luciferins.

Figure 3.

(A) Representative analogs of D-luciferin. Some of these molecules exhibit preferential reactivity with mutant luciferases, red-shifted emission, and/or improved bioavailability in organisms. (B) Representative analogs of coelenterazine. Some of these molecules exhibit unique reactivities with mutant luciferases, improved stability and solubility, and/or altered wavelengths of emission.